UV Stabilizer BTMPS in the Illicit Fentanyl Supply in 9 US Locations.
作者信息
Shover Chelsea L, Godvin Morgan E, Appley Meghan, Pyfrom Elise M, Castrillo Fernando Montero, Hochstatter Karli, Nadel Talia, Garg Neil, Koncsol Adam, Friedman Joseph R, Molina Caitlin A, Romero Ruby, Harshberger Brendan, Gonzalez Jordan A M, Spoliansky Jordan, Laurel Sarah, Jalayer Elham, Ruelas Juan, Gonzales John, Snakeoil Soma, Guerra Sonya, Arellano Oscar, Winstead Candace, Rybak Margaret, Champney Joanna, Waninger Brent, Torruella Rafael, Sisco Edward
机构信息
Division of General Internal Medicine and Health Services Research, University of California, Los Angeles.
National Institute of Standards and Technology, Gaithersburg, Maryland.
出版信息
JAMA. 2025 Mar 18;333(11):1000-1003. doi: 10.1001/jama.2024.27550.
Abstract
摘要
相似文献
1
UV Stabilizer BTMPS in the Illicit Fentanyl Supply in 9 US Locations.
JAMA. 2025 Mar 18;333(11):1000-1003. doi: 10.1001/jama.2024.27550.
2
The Rapid Spread of a Novel Adulterant in the US Illicit Drug Supply-BTMPS.
JAMA Intern Med. 2025 Sep 1;185(9):1057-1058. doi: 10.1001/jamainternmed.2025.2307.
3
Characterizing rapid changes in the prevalence and concentration of key compounds in Philadelphia's street opioid retail supply, March 2024-March 2025.
Drug Alcohol Depend. 2025 Sep 1;274:112763. doi: 10.1016/j.drugalcdep.2025.112763. Epub 2025 Jun 22.
4
Xylazine prevalence and concentration in the Los Angeles fentanyl market, 2023-2025.
Drug Alcohol Depend Rep. 2025 Jul 22;16:100364. doi: 10.1016/j.dadr.2025.100364. eCollection 2025 Sep.
5
Inhibition of nicotinic acetylcholine receptors by bis (2,2,6,6-tetramethyl- 4-piperidinyl) sebacate (Tinuvin 770), an additive to medical plastics.
J Pharmacol Exp Ther. 1994 Feb;268(2):718-26.
6
Xylazine Prevalence and Concentration in the Los Angeles Fentanyl Market, 2023 Q1 - 2025 Q2.
medRxiv. 2025 May 14:2025.05.13.25327478. doi: 10.1101/2025.05.13.25327478.
7
Quetiapine: A Novel Additive to the Illicit Heroin Supply in Los Angeles.
J Addict Med. 2025 Jul 25. doi: 10.1097/ADM.0000000000001552.
8
Fentanyl, Heroin, Methamphetamine, and Cocaine Analyte Concentrations in Urine Drug Testing Specimens.
JAMA Netw Open. 2024 Oct 1;7(10):e2441063. doi: 10.1001/jamanetworkopen.2024.41063.
9
Clinical characteristics of patients exposed to medetomidine in the illicit opioid drug supply in Philadelphia - a case series.
Clin Toxicol (Phila). 2025 Jun;63(6):438-441. doi: 10.1080/15563650.2025.2500601. Epub 2025 May 21.
10
Estimates of Illicit Opioid Use in the US.
JAMA Health Forum. 2025 May 2;6(5):e250809. doi: 10.1001/jamahealthforum.2025.0809.
引用本文的文献
1
Xylazine prevalence and concentration in the Los Angeles fentanyl market, 2023-2025.
Drug Alcohol Depend Rep. 2025 Jul 22;16:100364. doi: 10.1016/j.dadr.2025.100364. eCollection 2025 Sep.
2
High Variation in Purity of Consumer-Level Illicit Fentanyl Samples in Los Angeles, 2023-2025.
medRxiv. 2025 Jun 28:2025.06.27.25330446. doi: 10.1101/2025.06.27.25330446.
3
The Rapid Spread of a Novel Adulterant in the US Illicit Drug Supply-BTMPS.
JAMA Intern Med. 2025 Sep 1;185(9):1057-1058. doi: 10.1001/jamainternmed.2025.2307.
本文引用的文献
1
First Evidence of Hindered Amine Light Stabilizers As Abundant, Ubiquitous, Emerging Pollutants in Dust and Air Particles: A New Concern for Human Health.
Environ Sci Technol. 2024 Jan 16;58(2):1349-1358. doi: 10.1021/acs.est.3c08884. Epub 2024 Jan 3.
2
Hemodynamic Effects of the Light Stabilizer Tinuvin 770 in Dogs .
Open Med Chem J. 2018 Aug 31;12:88-97. doi: 10.2174/1874104501812010088. eCollection 2018.
3
Functional central nicotinic acetylcholine receptor antagonism by systemic administration of Tinuvin 770 (BTMPS).
Curr Alzheimer Res. 2005 Apr;2(2):141-7. doi: 10.2174/1567205053585747.
Zotero 插件